Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Amicus Therapeutics (FOLD)

Add to Watchlists
Create an Alert
1.85 -0.03  -1.60% NASDAQ Apr 23, 3:10PM BATS Real time Currency in USD
View Full Chart
FOLD Price Chart
View All Events

FOLD Events

Date Type Description
Mar 03 Misc Amicus Therapeutics, Inc. Q4 2013 Earnings Conference Call
Mar 03 Earnings Amicus Therapeutics, Inc. Q4 2013 Earnings Results. Estimate: -0.31.
Jan 16 Misc Amicus Therapeutics Provides Full-year 2014 Strategic Outlook and Financial Guidance
Nov 20 Misc Amicus Therapeutics Strategic Update Conference Call
Nov 12 Earnings Amicus Therapeutics Announces Third Quarter 2013 Financial Results. Estimate: -0.32.
Nov 12 Misc Amicus Therapeutics Announces Third Quarter 2013 Financial Results Conference Call
Aug 07 Misc Amicus Therapeutics Second Quarter 2013 Results Conference Call
Aug 07 Earnings Amicus Therapeutics to Announce Second Quarter 2013 Financial Results on August 7, 2013. Estimate: -0.33.
Jun 13 Misc AGM Event for Amicus Therapeutics Inc
May 09 Misc Amicus Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013
View All Performance Charts

FOLD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Amicus Therapeutics is down 39.74% over the last year vs S&P 500 Total Return up 22.69%, Actelion up 71.93%, and GlaxoSmithKline up 13.89%.

Get Quote for
Advertisement

Portfolio Strategies Featuring FOLD

Did Amicus Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

FOLD Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Amicus Therapeutics, Inc. is a biopharmaceutical company in the development stage. Its activities include raising capital, establishing facilities, and performing research and development.

Recent Quotes

Symbol Price Chg Chg % Market Cap
FOLD 1.85 -0.03 -1.60% 115.19M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.